Christopher Seder to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Christopher Seder has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
5.722
-
Robotic vs Thoracoscopic Anatomic Lung Resection in Obese Patients: A Propensity-Adjusted Analysis. Ann Thorac Surg. 2022 11; 114(5):1879-1885.
Score: 0.651
-
Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
Score: 0.628
-
Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al. Ann Surg Oncol. 2021 06; 28(6):3433-3434.
Score: 0.607
-
The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer. Ann Surg Oncol. 2020 Aug; 27(8):3030-3036.
Score: 0.587
-
Reply. Ann Thorac Surg. 2018 07; 106(1):316-317.
Score: 0.498
-
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
Score: 0.490
-
Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection. Lung. 2016 08; 194(4):619-24.
Score: 0.444
-
Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):55-61.e1.
Score: 0.443
-
Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules. Ann Thorac Surg. 2015 Aug; 100(2):429-36.
Score: 0.419
-
Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg. 2013 May; 95(5):1708-16.
Score: 0.359
-
The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer. Ann Thorac Surg. 2020 03; 109(3):848-855.
Score: 0.142
-
Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
Score: 0.127
-
Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum. J Immunoassay Immunochem. 2018; 39(1):84-98.
Score: 0.125
-
Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):307-16.
Score: 0.103
-
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
Score: 0.099